Bulletin From Extraordinary General Meeting in Senzime AB (publ)
At Senzime AB's extraordinary general meeting on October 23, 2024, shareholders unanimously approved the board's resolution for a directed share issue originally decided on September 27, 2024. The issue comprises a maximum of 1,104,000 shares at a subscription price of SEK 6.20 per share, with subscription rights granted to Adam Dahlberg and Sorin J. Brull. This will increase the company's share capital by up to SEK 138,000. The subscription deadline is set for October 28, 2024, and payment must be made in cash.
Nell'assemblea generale straordinaria di Senzime AB del 23 ottobre 2024, gli azionisti hanno approvato all'unanimità la risoluzione del consiglio per un emissione di azioni diretto originariamente decisa il 27 settembre 2024. L'emissione comprende un massimo di 1.104.000 azioni a un prezzo di sottoscrizione di SEK 6,20 per azione, con diritti di sottoscrizione concessi a Adam Dahlberg e Sorin J. Brull. Questo comporterà un aumento del capitale sociale dell'azienda fino a SEK 138.000. La scadenza per la sottoscrizione è fissata per il 28 ottobre 2024 e il pagamento deve essere effettuato in contante.
En la reunión general extraordinaria de Senzime AB del 23 de octubre de 2024, los accionistas aprobaron por unanimidad la resolución de la junta para una emisión de acciones dirigida originalmente decidida el 27 de septiembre de 2024. La emisión comprende un máximo de 1.104.000 acciones a un precio de suscripción de SEK 6,20 por acción, con derechos de suscripción otorgados a Adam Dahlberg y Sorin J. Brull. Esto aumentará el capital social de la empresa en hasta SEK 138.000. La fecha límite para la suscripción se establece en el 28 de octubre de 2024, y el pago debe hacerse en efectivo.
2024년 10월 23일 Senzime AB의 특별 주주 총회에서 주주들은 2024년 9월 27일에 결정된 지정 주식 발행에 대한 이사회의 결의를 만장일치로 승인했습니다. 이 발행은 1,104,000주의 최대 규모로 주당 SEK 6.20의 청약 가격을 보이며, 아담 달버그(Adam Dahlberg)와 소린 J. 브룰(Sorin J. Brull)에게 청약권이 부여됩니다. 이로 인해 회사의 자본금은 최대 SEK 138,000 증가할 것입니다. 청약 마감일은 2024년 10월 28일로 설정되었으며, 지불은 현금으로 이루어져야 합니다.
Lors de l'assemblée générale extraordinaire de Senzime AB du 23 octobre 2024, les actionnaires ont approuvé à l'unanimité la résolution du conseil concernant une augmentation de capital par émission d'actions dirigée initialement décidée le 27 septembre 2024. L'émission comprend un maximum de 1.104.000 actions à un prix de souscription de SEK 6,20 par action, avec des droits de souscription accordés à Adam Dahlberg et Sorin J. Brull. Cela permettra d'augmenter le capital social de la société jusqu'à SEK 138.000. La date limite de souscription est fixée au 28 octobre 2024 et le paiement doit être effectué en espèces.
Auf der außerordentlichen Hauptversammlung der Senzime AB am 23. Oktober 2024 genehmigten die Aktionäre einstimmig den Beschluss des Vorstands für eine gerichtete Aktienausgabe, die ursprünglich am 27. September 2024 beschlossen wurde. Die Ausgabe umfasst maximal 1.104.000 Aktien zu einem Bezugspreis von SEK 6,20 pro Aktie, wobei die Bezugrechte an Adam Dahlberg und Sorin J. Brull vergeben wurden. Dies wird das Grundkapital des Unternehmens um bis zu SEK 138.000 erhöhen. Die Frist für die Zeichnung ist auf den 28. Oktober 2024 festgelegt, und die Zahlung muss in bar erfolgen.
- None.
- Share dilution through directed issue of 1,104,000 new shares
UPPSALA, SWEDEN / ACCESSWIRE / October 23, 2024 / The extraordinary general meeting in Senzime AB (STO:SEZI)(OTCQX:SNZZF) (publ), corp. reg. no 556565-5734 (the "Company") was held on 23 October 2024, whereby the shareholders primarily resolved on the following matter. All resolutions were unanimous.
Resolution on the approval of the board of directors' resolution on a directed share issue
In accordance with previously published information, the board of directors resolved 27 September 2024 on a directed issue of shares, subject to the subsequent approval of the extraordinary general meeting. The general meeting resolved today to approve the board of directors' resolution on a directed issue of a maximum of 1,104,000 shares. The right to subscribe for new shares shall, with deviation from the shareholders' pre-emption rights, belong to Adam Dahlberg and Sorin J. Brull.
The Company's share capital will increase by a maximum of SEK 138,000 through a directed issue of a maximum of 1,104,000 shares. The subscription price for the shares in the new issue is SEK 6.20 per share. Subscription shall be made by cash payment or on a subscription list not later than 28 October 2024.
For further information, please contact:
Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com
Slavoljub Grujicic, CFO
Phone: +46 (0) 76 306 60 11, e-mail: slavoljub.grujicic@senzime.com
About Senzime
Senzime develops CE- and FDA-cleared precision-based patient monitoring solutions to safeguard patients during anesthesia and recovery. Senzime's TetraGraph® and ExSpiron® 2Xi systems are powered by proprietary, smart algorithms to monitor neuromuscular and respiratory function in real-time during and after surgery. The technologies are based on 40+ years of science and developed to enhance patient safety targeting over 100 million patients globally. Senzime's products are commercialized in over 30 countries including direct sales teams in US and Germany.
Established in 1999 and headquartered in Uppsala, Sweden, Senzime is backed by long-term investors and listed on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the New York OTCQX market (SNZZF). More information is available at senzime.com.
Attachments
Bulletin from extraordinary general meeting in Senzime AB (publ)
SOURCE: Senzime
View the original press release on accesswire.com
FAQ
What is the subscription price for Senzime's (SNZZF) new share issue announced on October 23, 2024?
How many new shares will be issued in Senzime's (SNZZF) October 2024 directed share issue?
When is the subscription deadline for Senzime's (SNZZF) directed share issue announced in October 2024?
How much will Senzime's (SNZZF) share capital increase through the October 2024 directed share issue?
